Strides Arcolab unit's Milan-based factory gets FDA OK

09/19/2013 | BioSpectrum Asia

The FDA has approved the drug facility of Strides Arcolab's Italian unit Beltapharm in Milan, allowing the company to enter the U.S. semisolid market. The facility will produce creams, ointments, semisolids and liquids, the drugmaker said in a statement. The facility is already cleared in Australia and the European Union.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC